
Senaparib Approved by NMPA for 1L Maintenance Therapy in Ovarian Cancer
IMPACT Therapeutics
Outdoor travel
IMPACT Therapeutics
International Copper Association
ROKT Pte. Ltd.
Hong Kong Pharma Digital Technology Holdings Limited
YABER TECHNOLOGIES CO., LIMITED